Biphasic anaphylaxis after use of foam polidocanol sclerotherapy

Abstract

Polidocanol is a sclerogenic agent commonly used for the treatment of varicose veins. Common complications such as hyperpigmentation, telangiectasia matting on skin may be observed in relation with foam sclerotherapy. Complications such as deep vein thrombosis, stroke and tissue necrosis are rarely seen. Fatal complications such as anaphylaxis are seen very uncommonly. A 50-year-old female patient underwent polidocanol foam sclerotherapy for left leg reticular varicosity (CEAP 2-3). Our patient has experienced biphasic anaphylaxis, which was observed as two attacks following the foam sclerotherapy. Biphasic anaphylaxis complication after the foam sclerotherapy is not known, this presentation may even be the first condition experienced ever.

Keywords

• Varicose vein
• polidocanol
• biphasic anaphylaxis

References

1. 1. Reina L. How to manage complications after sclerotherapy. Small saphenous vein interventional treatment. Phlebolymphology 2017;24:130-43.
2. 2. Rathbun S, Norris A, Stoner J. Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders. Phlebology 2012;27:105-17.
3. 3. Stricker BH, Van Oıjen JA, Kroon C, Ovink AH. Anaphylaxis following use of polidocanol. Nederlands tijdschrift voor geneeskunde1990;134:240-2.
4. 4. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification: Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
5. 5. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60.
6. 6. Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, et al. Allergic reactions to polidocanol for vein sclerosis: two case reports. J Dermatol Surg Oncol 1994;20:466-8.
7. 7. Alqurashi W, Ellis AK. Do corticosteroids prevent biphasic anaphylaxis? J Allergy Clin Immunol Pract 2017;5:1194-205.
8. 8. Oflu AT. [Anaphylaxy]. Kocatepe Med J 2015;16:77-82. [Article in Turkish]

9. 9. Cavezzi A, Parsi K. Complications of foam sclerotherapy. Phlebology 2012;27:46-51.
10. 10. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2015;3:408-16.
11. 11. Çeviker K, Şahinalp Ş, Çiçek E, Demir D, Uysal D, Yazkan R, et al. Quality of life in patients with chronic venous disease in Turkey: influence of different treatment modalities at 6-month follow-up. Qual Life Res 2016;25:1527-36.